Miranda Ramsey
Women's Health · Morganton, NCNPI 1003212234
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 24.9% of the total. Reporting peaked in 2021 at $906 and has fallen 84.3% since, to $142 in 2025. Among women's health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$651
- GSK$262
- Lilly USA, LLC$213
- Takeda Pharmaceuticals U.S.A., Inc.$203
- Astellas Pharma US Inc$137
- Novo Nordisk$130
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,49796%
- Education$1004%
- Entertainment$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $651 |
| GSK | 18 | $262 |
| Lilly USA, LLC | 16 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $203 |
| Astellas Pharma US Inc | 3 | $137 |
| Novo Nordisk | 8 | $130 |
| Axsome Therapeutics, Inc. | 4 | $120 |
| Gilead | 6 | $119 |
| Viiv Healthcare Company | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| AstraZeneca | 5 | $74 |
| Exact Sciences | 4 | $70 |
| Lundbeck LLC | 3 | $62 |
| Abbott | 2 | $49 |
| Pfizer | 3 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Novartis | 2 | $35 |
| Amgen | 2 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Organon | 2 | $20 |
| Seqirus USA Inc | 1 | $20 |
| Bayer | 1 | $20 |
| Edwards Lifesciences | 1 | $19 |
| Indivior Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Optos, Inc. | 1 | $13 |
How this compares
$2,610 in reported general payments places this provider in the 90th percentile of 158 women's health providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $8,083 |
| YuvafemEstradiol | 14 | $1,658 |
| Bupropion XlBupropion Hcl | 11 | $251 |
| Metoprolol Succinate | 12 | $182 |
| Tramadol Hcl | 12 | $107 |
| Levothyroxine Sodium | 21 | $106 |
| Simvastatin | 12 | $71 |
| Famotidine | 11 | $58 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 16 | $49 |
Paid to pharmacies, not to this prescriber.
Other women's health in Morganton
- Meredith HarrisRaleigh$241K
- Jami ChrzanowskiGreensboro$27K
- Amy KemmerlinCharlotte$8K
- Kylie CajkaCharlotte$5K
- Lindsey MosleyCharlotte$5K
- Lanika WrightGreenville$3K
- Melinda DavesHickory$3K
- Margaret DarstRaleigh$3K
- Kristin AllisonRaleigh$3K
- Tiffany MoonPlymouth$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.